Critically Ill Patients, Neutropenic Fever Patients, Patients With Hip Fractures
Conditions
Keywords
IPF Immature platelet fraction, ICU neutropenic fever, hip fracture, critically ill
Brief summary
Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever. The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients
Detailed description
In this study we have 3 groups of patients * Patients admitted to ICU * Patients admitted with neutropenic fever * Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge. At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients
Interventions
OTHERImmature Platelet Fraction
Sponsors
Dr. Yishai Ofran
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- Admission to hospital blood sample is taken between 24:00 pm till 15:00 pm
Exclusion criteria
* blood sample is taken after 15:00 pm in the first day of admission during the week * blood sample is taken on weekend: thursday 15:00 pm till saturday 24:00 pm
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to recovery from sepsis or time to death | 6 months | the primary outcome is the result of the patient's admission on which data analysis will be based |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Predicting value of IPF for prognosis | baeline 6 months | after the analysis of the data we'll may ba able to assess the predicting value of the IPF in predicting severity of infection and prediciting prognosis of infection in the three groups described |
Other
| Measure | Time frame | Description |
|---|---|---|
| clinical use of IPF as a prognostic factor | up to 12 months | this outcome is not uet based we need much more studies in order to be able to use IPF in daily clinical work |
Countries
Israel
Contacts
Primary ContactYishai Ofran, Doctor
Backup ContactDoaa Okasha, doctor
Outcome results
None listed